Disrupt CAD III
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Disrupt CAD III, covering 2024-02-01 to 2024-02-01. Get the full timeline:
Most recent: Clinical Trial Update: Disrupt CAD III Post-Approval Study (PAS)